AAAAAA

   
Results: 1-14 |
Results: 14
INHIBITORY ANTI-FACTOR-V ANTIBODIES BIND TO THE FACTOR-V C2 DOMAIN AND ARE ASSOCIATED WITH HEMORRHAGIC MANIFESTATIONS
Authors: ORTEL TL MOORE KD QUINNALLEN MA OKAMURA T SINCLAIR AJ LAZARCHICK J GOVINDAN R CARMAGNOL F KANE WH
Citation: Tl. Ortel et al., INHIBITORY ANTI-FACTOR-V ANTIBODIES BIND TO THE FACTOR-V C2 DOMAIN AND ARE ASSOCIATED WITH HEMORRHAGIC MANIFESTATIONS, Blood, 91(11), 1998, pp. 4188-4196
PROTEIN-S SELECTIVELY ACCELERATES THE APC CATALYZED CLEAVAGE AT BOTH ARGININE-306 AND ARGININE-679 IN FACTOR VA
Authors: WEI CJ QUINNALLEN MA KANE WH
Citation: Cj. Wei et al., PROTEIN-S SELECTIVELY ACCELERATES THE APC CATALYZED CLEAVAGE AT BOTH ARGININE-306 AND ARGININE-679 IN FACTOR VA, Blood, 90(10), 1997, pp. 638-638
ACTIVATED PROTEIN-C CATALYZED CLEAVAGE OF FACTOR-V AT ARGININE-506 RESULTS IN PARTIAL INACTIVATION OF THE COFACTOR
Authors: WEI CJ QUINNALLEN MA KANE WM
Citation: Cj. Wei et al., ACTIVATED PROTEIN-C CATALYZED CLEAVAGE OF FACTOR-V AT ARGININE-506 RESULTS IN PARTIAL INACTIVATION OF THE COFACTOR, Journal of investigative medicine, 44(3), 1996, pp. 214-214
FACTOR-V INHIBITORS ASSOCIATED WITH HEMORRHAGIC SYMPTOMS BIND TO A LIMITED REGION OF THE FACTOR VA LIGHT-CHAIN
Authors: ORTEL TL MOORE KD QUINNALLEN MA KANE WH
Citation: Tl. Ortel et al., FACTOR-V INHIBITORS ASSOCIATED WITH HEMORRHAGIC SYMPTOMS BIND TO A LIMITED REGION OF THE FACTOR VA LIGHT-CHAIN, Journal of investigative medicine, 44(3), 1996, pp. 233-233
RECOGNITION AND LYSIS OF HUMAN-MELANOMA BY A CD3(-) T-CELL CLONE RESTRICTED BY HLA-A2(), CD4(+), CD8()
Authors: DARROW TL ABDELWAHAB Z QUINNALLEN MA SEIGLER HF
Citation: Tl. Darrow et al., RECOGNITION AND LYSIS OF HUMAN-MELANOMA BY A CD3(-) T-CELL CLONE RESTRICTED BY HLA-A2(), CD4(+), CD8(), Cellular immunology, 172(1), 1996, pp. 52-59
SYSTEMATIC MUTAGENESIS OF ACTIVATED PROTEIN-C CLEAVAGE SITES IN FACTOR VA DEMONSTRATES THAT MULTIPLE CLEAVAGES ARE REQUIRED FOR COMPLETE INACTIVATION OF THE COFACTOR
Authors: WEI CJ QUINNALLEN MA KANE WH
Citation: Cj. Wei et al., SYSTEMATIC MUTAGENESIS OF ACTIVATED PROTEIN-C CLEAVAGE SITES IN FACTOR VA DEMONSTRATES THAT MULTIPLE CLEAVAGES ARE REQUIRED FOR COMPLETE INACTIVATION OF THE COFACTOR, Blood, 88(10), 1996, pp. 1751-1751
EXPRESSION AND CHARACTERIZATION OF RECOMBINANT FACTOR-V R506Q (FACTORV-LEIDEN)
Authors: WEI CJ QUINNALLEN MA KANE WH
Citation: Cj. Wei et al., EXPRESSION AND CHARACTERIZATION OF RECOMBINANT FACTOR-V R506Q (FACTORV-LEIDEN), Blood, 86(10), 1995, pp. 801-801
CLEAVAGE AT ARGININE-306 IS NOT REQUIRED FOR INACTIVATION OF FACTOR-VBY ACTIVATED PROTEIN-C (APC)
Authors: WEI CJ QUINNALLEN MA KANE WH
Citation: Cj. Wei et al., CLEAVAGE AT ARGININE-306 IS NOT REQUIRED FOR INACTIVATION OF FACTOR-VBY ACTIVATED PROTEIN-C (APC), Blood, 86(10), 1995, pp. 2446-2446
THROMBIN-CATALYZED ACTIVATION OF RECOMBINANT HUMAN FACTOR-V
Authors: KELLER FG ORTEL TL QUINNALLEN MA KANE WH
Citation: Fg. Keller et al., THROMBIN-CATALYZED ACTIVATION OF RECOMBINANT HUMAN FACTOR-V, Biochemistry, 34(12), 1995, pp. 4118-4124
LOCALIZATION OF FUNCTIONALLY IMPORTANT EPITOPES WITHIN THE 2ND C-TYPEDOMAIN OF COAGULATION-FACTOR V USING RECOMBINANT CHIMERAS
Authors: ORTEL TL QUINNALLEN MA KELLER FG PETERSON JA LAROCCA D KANE WH
Citation: Tl. Ortel et al., LOCALIZATION OF FUNCTIONALLY IMPORTANT EPITOPES WITHIN THE 2ND C-TYPEDOMAIN OF COAGULATION-FACTOR V USING RECOMBINANT CHIMERAS, The Journal of biological chemistry, 269(22), 1994, pp. 15898-15905
PURIFICATION AND CHARACTERIZATION OF THE 2ND C-TYPE DOMAIN OF HUMAN FACTOR-V EXPRESSED IN BACULOVIRUS
Authors: ORTEL TL QUINNALLEN MA KANE WH
Citation: Tl. Ortel et al., PURIFICATION AND CHARACTERIZATION OF THE 2ND C-TYPE DOMAIN OF HUMAN FACTOR-V EXPRESSED IN BACULOVIRUS, Blood, 84(10), 1994, pp. 10000387-10000387
PARTIAL GLYCOSYLATION AT ASPARAGINE-2181 OF THE 2ND C-TYPE DOMAIN OF HUMAN FACTOR-V IS THE STRUCTURAL BASIS OF THE LIGHT-CHAIN DOUBLET
Authors: ORTEL TL YOO L QUINNALLEN MA KANE WH
Citation: Tl. Ortel et al., PARTIAL GLYCOSYLATION AT ASPARAGINE-2181 OF THE 2ND C-TYPE DOMAIN OF HUMAN FACTOR-V IS THE STRUCTURAL BASIS OF THE LIGHT-CHAIN DOUBLET, Blood, 84(10), 1994, pp. 10000387-10000387
A FACTOR-V FACTOR-VIII LIGHT-CHAIN CHIMERA THAT EXPRESSES FACTOR-V PROCOAGULANT ACTIVITY AND IS RESISTANT TO NEUTRALIZATION BY A FACTOR-V INHIBITOR
Authors: ORTEL TL QUINNALLEN MA KELLER FG KANE WH
Citation: Tl. Ortel et al., A FACTOR-V FACTOR-VIII LIGHT-CHAIN CHIMERA THAT EXPRESSES FACTOR-V PROCOAGULANT ACTIVITY AND IS RESISTANT TO NEUTRALIZATION BY A FACTOR-V INHIBITOR, Thrombosis and haemostasis, 69(6), 1993, pp. 1046-1046
FUNCTIONAL-CHARACTERIZATION OF THROMBIN CLEAVAGE SITES IN HUMAN COAGULATION FACTOR-V USING SITE-DIRECTED-MUTAGENESIS
Authors: KELLER FG ORTEL TL QUINNALLEN MA KANE WH
Citation: Fg. Keller et al., FUNCTIONAL-CHARACTERIZATION OF THROMBIN CLEAVAGE SITES IN HUMAN COAGULATION FACTOR-V USING SITE-DIRECTED-MUTAGENESIS, Blood, 82(10), 1993, pp. 10000338-10000338
Risultati: 1-14 |